Cellectar Biosciences Announces USPTO Issues Formal Patent Allowance for CLR 1603
MADISON, Wis., Oct. 04, 2016 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB) (the “company”), an oncology-focused clinical stage biotechnology company, today announces that the United States Patent and Trademark Office (“USPTO”) has issued a …